AMPH - Amphastar Pharmaceuticals, Inc. Quarterly EPS earnings growth

Amphastar Pharmaceuticals (AMPH) - corporate logo

Quarterly earnings per share dynamics confirm the success of Amphastar Pharmaceuticals (AMPH) in developing high-tech injectables that create stringent barriers to entry for competitors. The value of 138.60 expresses the current value of the metric. Growth is driven by the monopoly pricing power of scarce medications with inelastic demand. Financial stability is supported by excess liquidity and a steady cash flow generated by high operating profitability.

amphastar.com (AMPH) Year-over-year earnings per one share growth for the last 12 months: for the period 07/04/2022 - 11/15/2026

Analytical breakdowns and data insights for company amphastar.com (AMPH)

- share price and expert price forecast:
Stock Price Amphastar|AMPH - Fair Value Consensus
- market capitalization statistics:
Market Capitalization Amphastar|AMPH - Total Enterprise Value
- balance sheet net asset value indicators:
Net Assets per Single Share Amphastar Pharmaceuticals|AMPH - Accounting Value of Company|Market Capitalization to Book Value Ratio amphastar.com|AMPH - Company Total Assets
- company liabilities and liquidity data:
Debt to Equity Amphastar Pharmaceuticals|AMPH - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Amphastar Pharmaceuticals|AMPH - Company Aggregate Indebtedness|Debts to Book Capitalization Amphastar Pharmaceuticals, Inc.|AMPH - Company Long-Term Loans and Borrowings|Company Short-Term Debts Amphastar Pharmaceuticals|Quick Liquidity amphastar.com
- earnings and market multiples details:
AMPH - Net Financial Result|Future Profit Amphastar Pharmaceuticals|AMPH - Market Price to Net Income Ratio|Forward P/E Multiple Amphastar Corp|AMPH - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Amphastar Pharmaceuticals, Inc.|AMPH - Income before deduction of interest, taxes and amortization|Net earnings per share for the last 12 months Amphastar Pharmaceuticals|AMPH - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months amphastar.com|AMPH - Earnings per share trend in current year|Earnings growth forecast for next year Amphastar Pharmaceuticals
- sales revenue and business income indicators:
AMPH - Company Sales Revenue|Projected Sales Volume Amphastar Pharmaceuticals Inc|AMPH - P/S Multiple|Price-to-Projected Revenue Ratio Amphastar Pharmaceuticals, Inc.|AMPH - Revenue Dynamics YoY (Last Twelve Months)
General company analysis:Amphastar - AMPH
Manufactured product of Amphastar Pharmaceuticals

This metric measures the percentage change in net income per share compared to the same quarter of the previous year. GURU.Markets tools visualize this quarterly earnings per share (EPS) growth to track business scaling rates. The line's dynamics depend directly on the efficiency of operating expense and revenue management. For Amphastar Pharmaceuticals (AMPH), such volatility reflects the margins of producing complex injectable drugs. Steady growth of this indicator confirms the competitive advantages of a vertically integrated model within the rare generics segment.

Who Amphastar Pharmaceuticals competes with

HLN: Quarterly EPS earnings growth|Kenvue Corp - Year-over-year earnings per one share growth for the last 12 months|VRNA (Verona Pharma PLC) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months jyongbio.com MENS|Year-over-year earnings per share growth for the last twelve months Ligand (LGND)|AMRX (Amneal) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Perrigo PRGO|Quarterly EPS earnings growth Alvotech Biopharmaceuticals ALVO|liquidia.com - Quarterly EPS earnings growth|GLPG - Quarterly EPS earnings growth|ANIP: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months MNKD|PCRX (Pacira Corp) - Quarterly EPS earnings growth|SPRY: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth TBPH|Year-over-year net earnings per share change for the last twelve months Aquestive Therapeutics, Inc.|Year-over-year earnings per share growth for the last twelve months scPharmaceuticals Inc. SCPH|TECX: Year-over-year earnings per share growth for the last 12 months|TNXP - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months SXT Pharmaceuticals SXTC|EPRX: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months bioharvest.com (BHST)|Year-over-year net earnings per share growth for the last 12 months EXOZ|ORMP: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Entera Bio Ltd. (ENTX)|HYFT (MindWalk Therapeutics) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ABVC (ABVC BioPharma, Inc)|Year-over-year earnings per one share growth for the last 12 months CPIX|QNTM - Year-over-year earnings per share growth for the last twelve months|FibroGen Corp (FGEN) - Year-over-year net earnings per share growth for the last 12 months|Telomir Pharmaceuticals Corp (TELO) - Year-over-year earnings per share growth for the last twelve months|Rani Therapeutics (RANI) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Synergy CHC Corp.|Earnings per share growth in annualized terms for the last twelve months rallybio.com RLYB|Quarterly EPS earnings growth LEXX|PULM: Year-over-year net earnings per share trend for the last twelve months|Pheton Holdings Ltd - Year-over-year net earnings per share growth for the last 12 months|APM - Year-over-year net earnings per share growth for the last 12 months|LYRA - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months IBO (Impact BioMedical)|TNF Pharmaceuticals Inc. (TNFA) - Year-over-year earnings per share growth for the last twelve months|cbdMD Corp - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months PRFX|Altamira Therapeutics (CYTO) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth LIPO|Quarterly EPS earnings growth optinose.com (OPTN)|Year-over-year earnings per share growth for the last twelve months Pieris Pharmaceuticals, Inc. PIRS|Procaps (PROC) - Earnings per share growth in annualized terms for the last twelve months|PTPI - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Qilian International Corp QLI|SLRN: Quarterly EPS earnings growth|Year-over-year net earnings per share trend for the last twelve months TFFP (tffpharma.com)